Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer.

Wang Y, Hinz S, Uckermann O, Hönscheid P, von Schönfels W, Burmeister G, Hendricks A, Ackerman JM, Baretton GB, Hampe J, Brosch M, Schafmayer C, Shevchenko A, Zeissig S.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov 30:158579. doi: 10.1016/j.bbalip.2019.158579. [Epub ahead of print]

PMID:
31794862
2.

Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical Prostatectomy.

Froehner M, Koch R, Farahzadi S, Heberling U, Borkowetz A, Twelker L, Baretton GB, Wirth MP, Thomas C.

Urol Int. 2019;103(4):427-432. doi: 10.1159/000500961. Epub 2019 Oct 29.

3.

Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.

Seidlitz T, Chen YT, Uhlemann H, Schölch S, Kochall S, Merker SR, Klimova A, Hennig A, Schweitzer C, Pape K, Baretton GB, Welsch T, Aust DE, Weitz J, Koo BK, Stange DE.

Gastroenterology. 2019 Dec;157(6):1599-1614.e2. doi: 10.1053/j.gastro.2019.09.026. Epub 2019 Oct 1.

4.

Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.

Borkowetz A, Froehner M, Rauner M, Conrad S, Erdmann K, Mayr T, Datta K, Hofbauer LC, Baretton GB, Wirth M, Fuessel S, Toma M, Muders MH.

Int J Cancer. 2019 Sep 11. doi: 10.1002/ijc.32679. [Epub ahead of print]

PMID:
31509606
5.

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.

Löck S, Linge A, Seidlitz A, Bandurska-Luque A, Nowak A, Gudziol V, Buchholz F, Aust DE, Baretton GB, Zöphel K, Steinbach J, Kotzerke J, Overgaard J, Zips D, Krause M, Baumann M, Troost EGC.

Radiother Oncol. 2019 Jun;135:43-50. doi: 10.1016/j.radonc.2019.02.020. Epub 2019 Mar 9.

PMID:
31015169
6.

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy.

Linge A, Schmidt S, Lohaus F, Krenn C, Bandurska-Luque A, Platzek I, von Neubeck C, Appold S, Nowak A, Gudziol V, Buchholz F, Baretton GB, Baumann M, Löck S, Krause M.

Clin Transl Radiat Oncol. 2019 Mar 18;16:40-47. doi: 10.1016/j.ctro.2019.03.002. eCollection 2019 May.

7.

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.

Stasik S, Salomo K, Heberling U, Froehner M, Sommer U, Baretton GB, Ehninger G, Wirth MP, Thiede C, Fuessel S.

Clin Biochem. 2019 Feb;64:60-63. doi: 10.1016/j.clinbiochem.2018.11.009. Epub 2018 Dec 4.

PMID:
30528938
8.

Gender and Mortality after Radical Cystectomy: Competing Risk Analysis.

Heberling U, Koch R, Hübler M, Baretton GB, Hakenberg OW, Wirth MP, Froehner M.

Urol Int. 2018;101(3):293-299. doi: 10.1159/000487445. Epub 2018 Aug 31.

PMID:
30173222
9.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG 2nd, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK.

Acta Neuropathol. 2018 Nov;136(5):779-792. doi: 10.1007/s00401-018-1899-7. Epub 2018 Aug 19.

PMID:
30123936
10.

Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.

Thiele S, Zimmer A, Göbel A, Rachner TD, Rother S, Fuessel S, Froehner M, Wirth MP, Muders MH, Baretton GB, Jakob F, Rauner M, Hofbauer LC.

Oncotarget. 2018 Jun 5;9(43):27293-27304. doi: 10.18632/oncotarget.25551. eCollection 2018 Jun 5.

11.

Erratum: Primary choriocarcinoma of the liver: a rare, but important differential diagnosis of liver lesions.

Kohler A, Welsch T, Sturm AK, Baretton GB, Reissfelder C, Weitz J, Riediger C.

J Surg Case Rep. 2018 May 18;2018(5):rjy110. doi: 10.1093/jscr/rjy110. eCollection 2018 May.

12.

Human gastric cancer modelling using organoids.

Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Grützmann K, Sommer U, Schweitzer C, Schölch S, Uhlemann H, Gaebler AM, Werner K, Krause M, Baretton GB, Welsch T, Koo BK, Aust DE, Klink B, Weitz J, Stange DE.

Gut. 2019 Feb;68(2):207-217. doi: 10.1136/gutjnl-2017-314549. Epub 2018 Apr 27.

13.

Primary choriocarcinoma of the liver: a rare, but important differential diagnosis of liver lesions.

Kohler A, Welsch T, Sturm AK, Baretton GB, Reissfelder C, Weitz J, Riediger C.

J Surg Case Rep. 2018 Apr 12;2018(4):rjy068. doi: 10.1093/jscr/rjy068. eCollection 2018 Apr. Erratum in: J Surg Case Rep. 2018 May 18;2018(5):rjy110.

14.

Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.

Borkowetz A, Renner T, Platzek I, Toma M, Herout R, Baunacke M, Groeben C, Huber J, Laniado M, Baretton GB, Froehner M, Zastrow S, Wirth MP.

Urol Int. 2018;100(2):155-163. doi: 10.1159/000486041. Epub 2018 Jan 16.

PMID:
29339663
15.

Direct endoscopy and diagnosis of adenocarcinoma following metal stent-based drainage of a pancreatic cyst.

Zeissig S, Schmelz R, Brückner S, Aust DE, Baretton GB, Hampe J.

Endoscopy. 2018 Mar;50(3):E72-E73. doi: 10.1055/s-0043-124182. Epub 2018 Jan 12. No abstract available.

PMID:
29329480
16.

Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.

Jarosch A, Sommer U, Bogner A, Reißfelder C, Weitz J, Krause M, Folprecht G, Baretton GB, Aust DE.

Oncoimmunology. 2017 Nov 7;7(2):e1393133. doi: 10.1080/2162402X.2017.1393133. eCollection 2018.

17.

Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.

Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, Appold S, Gudziol V, Nowak A, von Neubeck C, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S; DKTK-ROG.

Clin Cancer Res. 2018 Mar 15;24(6):1364-1374. doi: 10.1158/1078-0432.CCR-17-2345. Epub 2018 Jan 3.

18.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

Linge A, Schötz U, Löck S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M; DKTK-ROG.

Radiother Oncol. 2018 Apr;127(1):27-35. doi: 10.1016/j.radonc.2017.12.007. Epub 2017 Dec 30.

PMID:
29295747
19.

Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.

Solimena M, Schulte AM, Marselli L, Ehehalt F, Richter D, Kleeberg M, Mziaut H, Knoch KP, Parnis J, Bugliani M, Siddiq A, Jörns A, Burdet F, Liechti R, Suleiman M, Margerie D, Syed F, Distler M, Grützmann R, Petretto E, Moreno-Moral A, Wegbrod C, Sönmez A, Pfriem K, Friedrich A, Meinel J, Wollheim CB, Baretton GB, Scharfmann R, Nogoceke E, Bonifacio E, Sturm D, Meyer-Puttlitz B, Boggi U, Saeger HD, Filipponi F, Lesche M, Meda P, Dahl A, Wigger L, Xenarios I, Falchi M, Thorens B, Weitz J, Bokvist K, Lenzen S, Rutter GA, Froguel P, von Bülow M, Ibberson M, Marchetti P.

Diabetologia. 2018 Mar;61(3):641-657. doi: 10.1007/s00125-017-4500-3. Epub 2017 Nov 28.

20.

Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy.

Froehner M, Koch R, Hübler M, Heberling U, Novotny V, Zastrow S, Baretton GB, Wirth MP.

Eur Urol Focus. 2018 Apr;4(3):395-398. doi: 10.1016/j.euf.2016.10.003. Epub 2016 Oct 26.

PMID:
28753798
21.

Evaluation of Prostate Imaging Reporting and Data System Classification in the Prediction of Tumor Aggressiveness in Targeted Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy.

Borkowetz A, Platzek I, Toma M, Renner T, Herout R, Baunacke M, Laniado M, Baretton GB, Froehner M, Zastrow S, Wirth MP.

Urol Int. 2017;99(2):177-185. doi: 10.1159/000477263. Epub 2017 May 23.

PMID:
28531902
22.

[University Pathology in Germany].

Röcken C, Baretton GB, Kreipe HH, Kirchner T.

Pathologe. 2017 Jul;38(4):324-330. doi: 10.1007/s00292-017-0285-x. German. No abstract available.

PMID:
28432389
23.

[Current biomarkers for gastric cancer].

Baretton GB, Aust DE.

Pathologe. 2017 Mar;38(2):93-97. doi: 10.1007/s00292-017-0271-3. Review. German.

PMID:
28213714
24.

Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer.

Richter C, Herrero San Juan M, Weigmann B, Bergis D, Dauber K, Muders MH, Baretton GB, Pfeilschifter JM, Bonig H, Brenner S, Radeke HH.

Front Immunol. 2017 Jan 27;8:44. doi: 10.3389/fimmu.2017.00044. eCollection 2017.

25.

[Gastric tumors].

Baretton GB.

Pathologe. 2017 Mar;38(2):65-66. doi: 10.1007/s00292-017-0273-1. German. No abstract available.

PMID:
28175942
26.

Level of education and mortality after radical prostatectomy.

Froehner M, Koch R, Propping S, Liebeheim D, Hübler M, Baretton GB, Hakenberg OW, Wirth MP.

Asian J Androl. 2017 Mar-Apr;19(2):173-177. doi: 10.4103/1008-682X.178487.

27.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy.

Linge A, Löck S, Krenn C, Appold S, Lohaus F, Nowak A, Gudziol V, Baretton GB, Buchholz F, Baumann M, Krause M.

Clin Transl Radiat Oncol. 2016 Dec 22;1:19-26. doi: 10.1016/j.ctro.2016.10.002. eCollection 2016 Dec.

28.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG.

Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008. Epub 2016 Nov 29.

PMID:
27913065
29.

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.

Niessner H, Schmitz J, Tabatabai G, Schmid AM, Calaminus C, Sinnberg T, Weide B, Eigentler TK, Garbe C, Schittek B, Quintanilla-Fend L, Bender B, Mai M, Praetorius C, Beissert S, Schackert G, Muders MH, Meinhardt M, Baretton GB, Dummer R, Flaherty K, Pichler BJ, Kulms D, Westphal D, Meier F.

Clin Cancer Res. 2016 Dec 1;22(23):5818-5828. Epub 2016 Jun 15. Erratum in: Clin Cancer Res. 2017 Mar 1;23 (5):1361.

30.

A rare case of pancreatic endometriosis in a postmenopausal woman and review of the literature.

Plodeck V, Sommer U, Baretton GB, Aust DE, Laniado M, Hoffmann RT, Platzek I.

Acta Radiol Open. 2016 Sep 25;5(9):2058460116669385. eCollection 2016 Sep.

31.

[HER2 testing in gastric cancer - results of a German expert meeting].

Lordick F, Al-Batran SE, Hofheinz RD, Lorenzen S, Thuss-Patience P, Baretton GB, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A.

Z Gastroenterol. 2016 Aug;54(8):791-6. doi: 10.1055/s-0042-110794. Epub 2016 Aug 16. Review. German.

PMID:
27529529
32.

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA.

Stiller M, Sucker A, Griewank K, Aust D, Baretton GB, Schadendorf D, Horn S.

Oncotarget. 2016 Sep 13;7(37):59115-59128. doi: 10.18632/oncotarget.10827.

33.

The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis.

Visser K, Zierau O, Macejová D, Goerl F, Muders M, Baretton GB, Vollmer G, Louw A.

J Steroid Biochem Mol Biol. 2016 Oct;163:129-35. doi: 10.1016/j.jsbmb.2016.04.019. Epub 2016 Apr 30.

PMID:
27142456
34.

NRP2 transcriptionally regulates its downstream effector WDFY1.

Dutta S, Roy S, Polavaram NS, Baretton GB, Muders MH, Batra S, Datta K.

Sci Rep. 2016 Mar 30;6:23588. doi: 10.1038/srep23588.

35.

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.

Peitzsch C, Cojoc M, Hein L, Kurth I, Mäbert K, Trautmann F, Klink B, Schröck E, Wirth MP, Krause M, Stakhovsky EA, Telegeev GD, Novotny V, Toma M, Muders M, Baretton GB, Frame FM, Maitland NJ, Baumann M, Dubrovska A.

Cancer Res. 2016 May 1;76(9):2637-51. doi: 10.1158/0008-5472.CAN-15-2116. Epub 2016 Mar 16.

36.

Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists.

Schachschal G, Sehner S, Choschzick M, Aust D, Brandl L, Vieth M, Wegscheider K, Baretton GB, Kirchner T, Sauter G, Rösch T.

Int J Colorectal Dis. 2016 Mar;31(3):675-83. doi: 10.1007/s00384-016-2523-8. Epub 2016 Feb 4.

37.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.

Linge A, Löck S, Gudziol V, Nowak A, Lohaus F, von Neubeck C, Jütz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Bayer C, Belka C, Pigorsch S, Combs SE, Welz S, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Baumann M, Krause M; DKTK-ROG.

Clin Cancer Res. 2016 Jun 1;22(11):2639-49. doi: 10.1158/1078-0432.CCR-15-1990. Epub 2016 Jan 11.

38.

Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?

Froehner M, Propping S, Koch R, Borkowetz A, Liebeheim D, Toma M, Baretton GB, Wirth MP.

Urol Int. 2016;96(3):302-8. doi: 10.1159/000440729. Epub 2015 Oct 7.

PMID:
26440292
39.

[The metastatic niche. Mechanisms and prognostic implications].

Muders MH, Baretton GB.

Pathologe. 2015 Nov;36 Suppl 2:185-8. doi: 10.1007/s00292-015-0079-y. Review. German.

PMID:
26395891
40.

Brief Report: Endothelial-Specific X-Box Binding Protein 1 Deficiency Limits Tumor Necrosis Factor-Induced Leukocyte Recruitment and Vasculitis.

Ziogas A, Muders MH, Economopoulou M, Sprott D, Grossklaus S, Siegert G, Baretton GB, Mitroulis I, Chavakis T.

Arthritis Rheumatol. 2015 Dec;67(12):3279-85. doi: 10.1002/art.39309.

41.

Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.

Froehner M, Koch R, Heberling U, Novotny V, Oehlschlaeger S, Hübler M, Baretton GB, Hakenberg OW, Wirth MP.

Eur Urol. 2016 Jun;69(6):984-7. doi: 10.1016/j.eururo.2015.06.053. Epub 2015 Jul 17.

PMID:
26194042
42.

[Remove polyps and discard. Way or wrong way?].

Tannapfel A, Aust D, Baretton GB, Bläker H, Esposito I, Langner C, Vieth M, Wardelmann E, Kirchner T, Schirmacher P.

Pathologe. 2015 Mar;36(2):182-5. doi: 10.1007/s00292-015-0003-5. German. No abstract available.

PMID:
25855462
43.

Lee mortality index as comorbidity measure in patients undergoing radical cystectomy.

Froehner M, Koch R, Novotny V, Heberling U, Propping S, Litz RJ, Hübler M, Baretton GB, Hakenberg OW, Wirth MP.

Springerplus. 2015 Feb 3;4:55. doi: 10.1186/s40064-015-0834-9. eCollection 2015.

44.

RNA quality in fresh-frozen gastrointestinal tumor specimens-experiences from the tumor and healthy tissue bank TU Dresden.

Zeugner S, Mayr T, Zietz C, Aust DE, Baretton GB.

Recent Results Cancer Res. 2015;199:85-93. doi: 10.1007/978-3-319-13957-9_9.

PMID:
25636432
45.

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, von Neubeck C, Baretton GB, Löck S, Thames HD, Krause M, Baumann M; DKTK-ROG.

Radiother Oncol. 2014 Dec;113(3):317-23. doi: 10.1016/j.radonc.2014.11.011. Epub 2014 Dec 2.

46.

WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.

Thiele S, Göbel A, Rachner TD, Fuessel S, Froehner M, Muders MH, Baretton GB, Bernhardt R, Jakob F, Glüer CC, Bornhäuser M, Rauner M, Hofbauer LC.

J Bone Miner Res. 2015 Mar;30(3):471-80. doi: 10.1002/jbmr.2362.

47.

Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy.

Froehner M, Novotny V, Heberling U, Rutsch L, Litz RJ, Hübler M, Koch R, Baretton GB, Wirth MP.

Eur Urol. 2014 Dec;66(6):987-90. doi: 10.1016/j.eururo.2014.07.046. Epub 2014 Aug 19.

PMID:
25150172
48.

Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.

Toma MI, Erdmann K, Diezel M, Meinhardt M, Zastrow S, Fuessel S, Wirth MP, Baretton GB.

PLoS One. 2014 Jul 15;9(7):e102262. doi: 10.1371/journal.pone.0102262. eCollection 2014.

49.

Identification and functional validation of RAD23B as a potential protein in human breast cancer progression.

Linge A, Maurya P, Friedrich K, Baretton GB, Kelly S, Henry M, Clynes M, Larkin A, Meleady P.

J Proteome Res. 2014 Jul 3;13(7):3212-22. doi: 10.1021/pr4012156. Epub 2014 Jun 19.

PMID:
24897598
50.

An exotic cause of exudative enteropathy.

Tsourdi E, Heidrich FM, Winzer M, Röllig C, Kirsch C, Meinel J, Baretton GB, Bornstein SR, Hofbauer LC.

Am J Case Rep. 2014 May 22;15:226-9. doi: 10.12659/AJCR.890483. eCollection 2014.

Supplemental Content

Loading ...
Support Center